Startup
Pikralida
Startup · Warsaw, Poland
Biotech drug-discovery company developing PKL-021, a small-molecule MMP inhibitor program for acute neuroprotection after stroke and traumatic brain injury, with additional applications in field-ready snakebite treatment.
Connection map
Affiliation
Drag nodes to rearrange · scroll or pinch to zoom · click a node to open it